Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063236 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Patricia Magadán-Corpas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Group BIONUC (Biotechnology of Nutraceuticals and Bioactive Compounds), Departamento de Biología Funcional, Área de Microbiología, Universid…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Colitis, Propiophenones. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Gobierno del Principado de Asturias, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory disorder affecting the colon, with symptomatology influenced by factors including environmental, genomic, microbial, and immunological interactions. Gut microbiota dysbiosis, characterized by bacterial population alterations, contributes to intestinal homeostasis disruption and aberrant immune system activation, thereby exacerbating the inflammatory state. This study assesses the therapeutic efficacy of intraperitoneal (IP) injected flavonoids (apigenin, luteolin, and xanthohumol) in the reduction of inflammatory parameters and the modulation of the gut microbiota in a murine model of ulcerative colitis. Flavonoids interact with gut microbiota by modulating their composition and serving as substrates for the fermentation into other anti-inflammatory bioactive compounds. Our results demonstrate the effectiveness of luteolin and xanthohumol treatment in enhancing the relative abundance of anti-inflammatory microorganisms, thereby attenuating pro-inflammatory species. Moreover, all three flavonoids exhibit efficacy in the reduction of pro-inflammatory cytokine levels, with luteolin strongly demonstrating utility in alleviating associated physical UC symptoms. This suggests that this molecule is a potential alternative or co-therapy to conventional pharmacological interventions, potentially mitigating their adverse effects. A limited impact on microbiota is observed with apigenin, and this is attributed to its solubility constraints via the chosen administration route, resulting in its accumulation in the mesentery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group BIONUC (Biotechnology of Nutraceuticals and Bioactive Compounds), Departamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo, 33006 Oviedo, Spain.
- IUOPA (Instituto Universitario de Oncología del Principado de Asturias), 33006 Oviedo, Spain.
- ISPA (Instituto de Investigación Sanitaria del Principado de Asturias), 33006 Oviedo, Spain.
- Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.
ORCID-Profile: Álvaro Pérez-Valero, Suhui Ye, Sandra Sordon, Ewa Huszcza, Felipe Lombó
Förderung
- European Union
- Gobierno del Principado de Asturias
- Ministerio de Ciencia e Innovación
- Principado de Asturias (Spain)
- MICINN (Spanish Ministry of Science and Innovation)
- European Union’s Horizon 2020 Research and Innovation Program
Zitieren
APA
Magadán-Corpas, P., Pérez-Valero, Á., Ye, S., Sordon, S., Huszcza, E., Popłoński, J., Villar, C. J., & Lombó, F. (2024). Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063236
Vancouver
Magadán-Corpas P, Pérez-Valero Á, Ye S, Sordon S, Huszcza E, Popłoński J, et al. Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063236
BibTeX
@article{MagadnCorpas2024,
author = {Magadán-Corpas, Patricia and Pérez-Valero, Álvaro and Ye, Suhui and Sordon, Sandra and Huszcza, Ewa and Popłoński, Jarosław and Villar, Claudio J and Lombó, Felipe},
title = {Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063236}
}
EUVIMED